Effect of Carbomer as an Adjuvant for Enhancement of Immune-Response Against FMD Vaccine | ||||
| Journal of Applied Veterinary Sciences | ||||
| Article 4, Volume 6, Issue 2, April 2021, Page 27-36 PDF (1.03 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/javs.2021.154578 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Walaa S. Shabana  1; Abeer Abd EL-Sadek2
| ||||
| 1Foot and Mouth Disease Research Department , Veterinary Serum and Vaccine Research Institute (VSVRI), Agricultural Research Center (ARC), Abassia, Cairo, Egypt. | ||||
| 2Department of Infectious Diseases, Faculty of Veterinary Medicine, El-Wadi El-Gadid University, Egypt. | ||||
| Abstract | ||||
| This work was designed to provide high protective, long-lasting immunity against FMD by enhancing the immunogenicity of the trivalent FMD vaccine using carbomer as adjuvant using G. pigs as an alternative cheapest animal model for quality control testing of the prepared FMD vaccines formulae. Guinea pigs were chosen as experimental models to develop concepts and techniques to study the PD50 of FMD vaccines because of the similarities of clinical symptoms in these animals to those of swine and cattle to saving cost, three different formulae of inactivated trivalent FMD vaccine including serotypes O Pan Asia2, A Iran O5 and SAT2/EGY/2012 were prepared as formula 1- (50% carbomer to 50% antigen); formula 2 (50% Montanide ISA 206 to 50%antigen) and formula 3- (25% Montanide ISA 206 and 25% carbomer with 50 % antigen). All of such formulae were found to be free from foreign contaminants, safe and potent, showing no postvaccinal reactions and high protective levels of specific FMD antibodies in Guinea pigs. Each vaccine formula's immunogenicity was determined by estimation of 50% Guinea pig protective dose (GPPD50) and monitoring of the humeral antibody response of vaccinated G. Pig groups. It was found that Montanide oils 206 with carbomer is the best vaccine formula, followed by Montanide oils 206 and finally carbomer which give early short-lasting immunity. | ||||
| Keywords | ||||
| Adjuvants; Carbomer; FMD; Montanide ISA206 | ||||
| References | ||||
|
ABD EL-ATY, SM, FAKRY, HM, HIND, MD, EL-SAYED, EI, WAEL MG, RIZK, SA, ABU-ELNAGA, H., MOHAMED, AA, ABD EL-KREEM, A. AND FAROUK EM 2013.Isolation and Molecular characterization of foot and mouth disease sat2 virus during outbreak 2012 in Egypt. J. Vet. Adv., 3(2): 60-68.
Abd El-Rahman, A. O., Farag, M. A., Samira El- Kilany, Eman, M. A., Manal Abo El Yazed and Zeidan, S. 2006.Isolation and identification of FMDV during an outbreak of 2006 in Egypt. Kafr El- Sheikh Vet. Med. J.; 4(1).
Ahmed HA, Salem SA, Habashi AR, Arafa AA, Aggour MG, Salem GH, Gaber AS, Selem O, Abdelkader SH, Knowles NJ, Madi M, Valdazo-González B, Wadsworth J, Hutchings GH, Mioulet V, Hammond JM, King DP 2012. Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012. Transbound Emerg Dis. 2012 Dec;59(6):476-81. doi: 10.1111/tbed.12015.
AIDAROS, HA 2002 Regional status and approaches to control and eradication of FMD in the middle east and North Africa. Rev. Sci. Tech. Off. Int. Epizoot., 21(3): 451-458.
Alkan M., S. Gurcan, M. F. Sarac, Y. Gultekin, A. Arslan, E. Uzunlu, S. Akyuz and G. Aynagoz 2008.Development of a Foot and Mouth disease vaccine potency tests without conducting animal challenge experiment. The Global control of FMD - Tools, ideas and ideals – Erice, Italy 14-17 October 2008, pp.181-186
Assem Abu Bakr Mohamed 2010.Trial for preparation of bivalent oil adjuvant FMD vaccine. Ph. D Faculty of Veterinary Medicine, Department of Microbiology Alexandria University.
Barteling SJ AND Cassim NI 2004. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde. Dev Biol (Basel).,119: 449-55.
Bartelling, A. S. J., Van Maanan, C., Yadin, H. and Anemaet, D. A. J. 1990. A Foot and Mouth Disease vaccine bank; purified inactivated antigen stored at ultra-low temperatures for the rapid preparation of double oil emulsion vaccines. European commission for control of Foot and Mouth Disease. Session of Research Group of the standing technical Committee, Lindholm, 172-177.
BLACK; FRANCIS, MJ; RWEYEMAMU, MM; UMEHARA, O. AND BOGE, A. 1985. The relationship between serum antibody titers and protection from foot and mouth disease in pigs after oil emulsion vaccination. J.Biol.Stand., 12(4): 379-389.
Challa, S., Szczepanek, S.M., Rood , D., Barrette, R.W., Silbart, L.K., 2011. Bacterial Toxin Fusion Proteins ElicitMucosal Immunity against a Foot-and-Mouth DiseaseVirus Antigen When Administered Intranasally toGuinea Pigs. Advances in Virology 2011:713769.Epub 2011 Sep 22.
DEPA, P.M., DIMRI, U., SHARMA, MC, AND TIWARI, R. 2012. Update on epidemiology and control of foot and mouth disease - A menace to international trade and global animal enterprise. Vet. World, 5(11): 694-704.
Dey AK, Burke B, Sun Y, Hartog K, Heeney JL, Montefiori D. 2012. Use of a polyanionic carbomer, Carbomere971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine; 30:2749-59.
Doel TR 2003FMD vaccines. Virus Res 91: 81-99.
DOEL, TR, CHONG, WKT, 1982. Comparative immunogenicity of 146s, 75s, and 12s particles of FMDV. Arch. Virol. 73, 185/191.
EL-SAYED, EIM, 2011. Advanced studies on Foot and Mouth Disease Vaccines of sheep in Egypt. Ph D.Sc. Thesis (Infectious Diseases), Faculty of Veterinary Medicine, Cairo University, Egypt.
El-Sayed, E I and Salma A Shoulah. 2021 "Effect of Carbopol as an Immune-Stimulant in Bovine Vaccination against Foot and Mouth Disease." EC Veterinary Science 6.1: 37-47.
El-Sayed E, Wael Mossad Gamal El-Din, Sonia Ahmed Rizk and Magdi Abd El-Aty 2012.Effect of Different Storage Temperatures on the Efficacy of the Bivalent Foot and Mouth Disease Oil Vaccine. Journal of Advanced Veterinary Research Volume 2, pp.198-205
Eman M, EL- Garf 2012 Using of guinea Pigs as animal model to determine the PD50 of local oil bivalent FMD vaccine. 7th Int. Sci. Conf., Mansoura 28-30 August. Pp. 797-809.
FERREIRA, MEV 1976.Microtiter neutralization test for the study of FMD antibodies. Bol. Centro Pan Americano de Fiebre Aftosa, 21: 22-23.
Gamil MA 2010. Studies on the immune response of calves vaccinated inactivated bivalent FMD virus vaccine type O1 and A Egypt 2006. M. V. Sc in Veterinary Science (virology). Benha University
GARTLAN KATE H., GEORGE KRASHIAS, FRANK WEGMANNA, WILLIAM R. HILLSONA, ERIN M. SCHERER, PHILIP D. GREENBERG, STEPHANIE C. EISENBARTH, AMIN E. MOGHADDAMA, QUENTIN J. SATTENTAUA 2016. Sterile inflammation induced by Carbomere elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns. Vaccine, http://dx.doi.org/10.1016/j.vaccine. 03.025
Grubman MJ, Baxt B 2004 Foot-and-mouth disease. Clin Microbiol Rev 17:465-493
Gualandi GL, Losio NM, Muratori G, Foni E. 1988. The ability by different preparations of porcine parvovirus to enhance humoral immunity in swine and guinea pigs. Microbiologica; 11:363–9.
Health protection Agency 2009. Complement fixation tests. Issue no:3 Issue date 11.12.09 Issued by standards unit, Department for Evaluations, standards and Training page 1 of 23.
Hoogland MJ, Opriessnig T, Halbur PG. 2006. Effects of adjuvants on porcine circovirus type 2-associated lesions. J Swine Health Prod; 14:133–9.
ISMAIL, A.H., EL-MAHDY, S.A., MOSSAD, WG, ABD EL-KRIM, AS, ABOU EL-YAZID, M. AND ALI, S.M 2013. Optimization of the inactivation process of FMD virus serotype SAT-2 by binary ethyleneimine (BEI). J. Vet, Adv., 3(3): 117-124.
Jacqueline Gelfi, Michael Pappalardo, Carine Claverys, Brigitte Peralta, Jean-Luc Guerin 2011. Safety and efficacy of an inactivated Carbomere-adjuvanted Goose haemorrhagic polyomavirus vaccine for domestic geese. Avian Pathology, Taylor & Francis, 39 (02), pp.111-116.
Knowles Nick J., Jemma Wadsworth, Scott M. Reid, Katherine G. Swabey, Alaa A. El-Kholy, Adel Omar Abd El-Rahman, Hatem M. Soliman, Katja Ebert, Nigel P. Ferris, Geoffrey H. Hutchings, Robert J. Statham, Donald P. King, and David J. Paton 2007. Foot-and-Mouth Disease Virus Serotype A in Egypt. Emerg Infect Dis. 2007 October; 13(10): 1593–1596. doi: 10.3201/eid1310.070252
Krashias G, Simon AK, Wegmann F, Kok WL, Ho LP, Stevens D. 2010 Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. Vaccine; 28:2482–9.
Lai RP, Seaman MS, Tonks P, Wegmann F, Seilly DJ, Frost SD. 2012. Mixed adjuvant formulations reveal a new combination that elicits antibody response comparable to Freund's adjuvants. PLoS ONE;7:e35083.
Liu IK, Turner Jr JW, Van Leeuwen EM, Flanagan DR, Hedrick JL, Murata K. 2005.Persistence of anti-zonae pellucidae antibodies following a single inoculation of porcine zonae pellucidae in the domestic equine. Reproduction; 129:181–90.
Mair KH, Koinig H, Gerner W, Hohne A, Bretthauer J, Kroll JJ. 2015. Carbomer improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS((R)) MLV. Vet Microbiol; 176:352–7.
MINKE, JM, TOULEMONDE, CE, DINIC, S., COZETTE, V., CULLINANE, A. & AUDONNET, J. C. 2007. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. Journal of Comparative Pathology, 137, Supplement 1: S76-80.
Morgan DO, Bachrach HL, McKercher PD. 1969. Immunogenicity of nanogram to milligram quantities of inactivated foot-and-mouth disease virus. Part I. Relative virus-neutralizing potency in guinea pig sera. Appl Microbiol; 17(3): 441–5.
MOTAMEDI SEDEH F., A. KHORASANI, K. SHAFAEE, M. SALEHIZADEH, H. FATOLAHI, K. ARBABI, S. DANESHVARI AND M. ABHARI 2007.immune response of foot and mouth disease virus type a87/irn inactivated vaccine by gamma irradiation on Guinea pig in Iran, Iranian Journal of Science & Technology, Transaction A, Vol. 31, No. A1
Mumford JA, Wilson H, Hannant D, Jessett DM. 1994. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect; 112:421–37.
NAGLAA I. ALY, OMAIMA A. EL-SHAMANDY, SHENDY, MB; FATMA F. WARDA; and Ekbal, M. Farouk 2020. Efficacy of using carbomer as an adjuvant for Tissue Culture Inactivated Rabies Vaccine. Journal of Applied Veterinary Sciences, 5(3): 103-107
OIE 2017. FMD, Chapter 2.1.5. In manual of Standard for Diagnostic Test and Vaccine, Paris, pp.77-92.
Parida Satya 2009. Vaccination against foot‑and‑mouth disease virus: strategies and effectiveness Expert Rev. Vaccines 8(3), 347-365
Pay TWF, Hingley PJ. 1987.Correlation of 140 S antigen dose, the serum-neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 1987; 5:60-4.
REED, L.J. AND MUENCH, H. 1938. A simple method for estimating fifty percent (50%) endpoints. Am. J. Hyg., 27: 493-497.
RICHARD C. KNUDSEN, CHRISTOPHER M. GROOCOCK, AND ARTHUR A. ANDERSEN 1979. Immunity to Foot-and-Mouth Disease Virus in Guinea Pigs: Clinical and Immune Responses. Infection And Immunity, June 1979, p. 787-792 Vol. 24, No. 3
Samira El-Kilany, El- Watany, H., Abd El-Rahman, A.O., Fadia Fahmy, 1999. The effect of long-term storage at4°C on the stability of FMD vaccine formulated withdifferent adjuvants. Alexandria Journal of VeterinarySciences 15 (1), 35-42.
Satya, P. 2009.Vaccination against foot-and-mouth disease virus: Strategies and effectiveness. Expert Rev. Vaccines, 8(3): 347-365.
Shawky M., Abd El-Aty M., Hiam. M. Fakry, Hind M. Daoud, Ehab El-Sayed I., Wael Mossad G., Sonia A. Rizk, Abu-Elnaga H., Mohamed A. A., Abd El-kreem A. and Farouk E. M. 2013.Isolation and Molecular Characterization of Foot and Mouth Disease SAT2 Virus during Outbreak 2012 in Egypt. J Vet Adv 2013, 3(2): 60-68. DOI: 10.5455/jva.20130219104353
Shiari J., chatchawanchonteera A., Sinsuwongwat W., Makarasen P. and Sugimura T. 1990. Estimation of 140S particles in FMD virus vaccine by using the computer analyzing system. Jap. J. Vet. Sci., 52(3): 621 – 630.
Sonia Rizk 2007. Studies on the preparation of an improved Foot and Mouth Disease oil vaccine. Ph. D. Thesis, University of Cairo
STONE, HD 1988. Optimization of hydrophile-lipophile balance for improved efficacy of ND and avian influenza oil emulsion vaccines. Avian Disease, 32: 68-73.
Tollersrud T, Norstebo PE, Engvik JP, Andersen SR, Reitan LJ, Lund A. 2002.Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants. Vet Res Communication; 26:587–600.
Vereecken M., De Herdt P., Ducatelle R. and Haesebrouck, F. 2000The effect of vaccination on the course of an experimental Salmonella Typhimurium infection in racing pigeons. Avian Pathology, 29, 465- 471.
VOLLER, A., BID WELL, D. AND BARTLEHA 1976. Microplate enzyme immunoassay for the immunodiagnosis of virus infection. Am. Soc. For Micro. (506-512).
Xuan H., Li Y., Fang, H. and Zheng, C. 2011. Establishment of persistent infection with foot and mouth disease virus in BHK-21 cells. Virol. J., 8: 169. | ||||
|
Statistics Article View: 427 PDF Download: 542 |
||||
